Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma

PHASE1TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

January 31, 2013

Conditions
Melanoma
Interventions
BIOLOGICAL

naked DNA coding for protein AMEP

2 injections 1 week interval of 4 increasing doses of plasmid with electrotransfer

Trial Locations (3)

2730

Copenhagen University Hospital Herlev, Herlev

94805

Gustave Roussy Institute, Le Kremlin-Bicêtre

SI-1000

Institute of Oncology Ljubljana, Ljubljana

Sponsors
All Listed Sponsors
lead

Valerio Therapeutics

INDUSTRY

NCT01045915 - Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma | Biotech Hunter | Biotech Hunter